Isabelle Posmantur

Isabelle joined LifeSci Consulting as an Analyst in August 2022 and has since supported a range of strategic engagements across commercial strategy, market access, opportunity assessments, indication prioritization, and investor-facing analyses. Her work spans several therapeutic areas, with a particular focus in immunodermatology, neurology, and rare diseases. Prior to joining LifeSci, Isabelle gained experience across biomedical research, precision healthcare, and healthcare investing through roles at Emory University’s Lab of Biomedical Pharmacology, Human Longevity, 25Madison, and Arcadian Capital. Isabelle received her B.A. in Neuroscience from the University of Pennsylvania.